COVID-19 testing
-
XPhyto Therapeutics Launches Rapid Test for COVID-19, Zacks Research Initiates Coverage
XPhyto Therapeutics Corp. (CSE: XPHY | OTCQB: XPHYF | FSE: 4XT) (“XPhyto”) is a bioscience company with a…
-
Using StageZero Life Sciences as a Case Study for the Publication of All Research Reports Online
Analyst Chris Thompson published a piece on eResearch on StageZero Life Sciences Ltd. (TSX: SZLS) this weekend titled,…
-
StageZero’s New Cancer-Testing Platform and Health Clinics Acquisition Forms Telemedicine “Circle of Care”
StageZero Life Sciences Ltd. (TSX: SZLS) is a life science and telehealth company that recently launched Aristotle®, which…
-
StageZero Life Sciences’ Aristotle 10 in 1 cancer screening test looks set to launch in Q1 2021
StageZero Life Sciences Ltd. (TSX: SZLS) (‘StageZero’) has been developing their Aristotle 10 in 1 cancer screening test…
-
StageZero Saliva PCR Test, a potential game changer for replacing the nasal probe
Nobody likes a COVID-19 nasal swab test that pushes a probe way up into your nose nearly reaching…
